The Wistar Institute
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
8
Ending by 2030
Jan 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 18, 2027The maintenance fee for Adenoviral vectors comprising partial deletions of E3 (US 11,702,675) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
- 1 fee due Mar 10, 2027The maintenance fee for Adenoviral vectors comprising partial deletions of E3 (US 10,407,696) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
- 1 fee due Jun 5, 2027The maintenance fee for Substituted Chromenones, IRE1 Inhibitors, and Methods of Using Same (US 11,833,137) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
- 1 fee due Jul 12, 2027The maintenance fee for Screening method and compounds for modulating telomerase activity (US 9,234,230) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
- 1 fee due Oct 12, 2027The maintenance fee for Compositions and methods for modulating the activity of Epstein-Barr nuclear antigen 1 (US 9,309,212) comes due Oct 12, 2027. Unpaid by Apr 12, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
- 1 term has ended since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,838,236 | VPR function and activity In force · From the USPTO record | In force | From the USPTO record | |
| US 8,234,080 | Method for identifying a compound that modulates telomerase activity In force · From the USPTO record | In force | From the USPTO record | |
| US 8,338,392 | Microrna Modulators and Method for Identifying and Using the Same In force · High confidence | In force | High confidence | |
| US 8,180,580 | Method for identifying a compound that modulates SIR2 protein activity In force · From the USPTO record | In force | From the USPTO record | |
| US 8,374,838 | Method for identifying a compound that modulates telomerase activity In force · From the USPTO record | In force | From the USPTO record | |
| US 8,377,992 | TRBD-binding effectors and methods for using the same to modulate telomerase activity In force · From the USPTO record | In force | From the USPTO record | |
| US 9,234,230 | Screening method and compounds for modulating telomerase activity In force · From the USPTO record | In force | From the USPTO record | |
| US 8,518,940 | FP-pocket-binding effectors and methods for using the same to modulate telomerase activity In force · From the USPTO record | In force | From the USPTO record | |
| US 9,309,212 | Compositions and methods for modulating the activity of Epstein-Barr nuclear antigen 1 In force · From the USPTO record | In force | From the USPTO record | |
| US 9,624,510 | Adenoviral vectors comprising partial deletions of E3 In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 25: 8 patents in force now held by others · 8 lapsed for an unpaid fee · 65 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
6 pending · 4 abandoned · 15 no status recorded